序号 |
标题 |
次数 |
作者 |
发布时间 |
80191 |
螯合剂多肽cyclo(RGDFK(DOTA)) ,DOTA-c(RGDfK) |
94 |
wyh |
2024-11-29 |
80192 |
NOTA-(COOt-Bu)2 cas:1161415-28-6 |
88 |
zyl |
2024-11-29 |
80193 |
DOTA-JR10多肽的功能特点 |
137 |
wyh |
2024-11-29 |
80194 |
Biotin-Gd-DOTA ;生物素修饰的钆 |
72 |
wyh |
2024-11-29 |
80195 |
DOTA-CC9 ,细胞膜的环肽CC9偶联DOTA |
185 |
kx |
2024-11-29 |
80196 |
1,4,7,10-四氮杂环十二烷-N.N ',N ",N " '-四乙酸(H4DOTA) |
238 |
kx |
2024-11-29 |
80197 |
NOTA-bis-COOH-Me-Tetrazine 大环配体NOTA-三羧酸-甲基四嗪 |
76 |
zyl |
2024-11-29 |
80198 |
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[(diphosphonomethyl)amino]-2-oxoethyl]- 定制 |
96 |
zcy |
2024-11-29 |
80199 |
DOTA-pNO2Phe-c[DCys-Tyr-DTrp-Lys-Thr-Cys]-DTyr-NH2 |
122 |
kx |
2024-11-29 |
80200 |
MeTz-PEG7-NOTA 甲基四嗪-聚乙二醇-大环化合物 Me-Tetrazine-PEG7-NOTA |
69 |
zyl |
2024-11-29 |
80201 |
DOTAGA-四叔丁酯,306776-79-4,DOTAGA-(COOt-Bu)4 |
159 |
zcy |
2024-11-29 |
80202 |
金刚烷改性氰酸酯树脂 AD-CE |
180 |
h |
2024-11-29 |
80203 |
DOTA-Tyr-Lys-DOTA ;DOTA-酪氨酸-赖氨酸-DOTA |
64 |
wyh |
2024-11-29 |
80204 |
HA-DOTA tate , DOTA-3-碘-Tyr 3-奥曲肽 , HA-DOTATATE |
96 |
kx |
2024-11-29 |
80205 |
NOTA-E(cRGDfK)2 , NOTA修饰多肽 |
100 |
wyh |
2024-11-29 |
80206 |
叠氮-NOTA cas:2125661-92-7 NOTA-Azide/N3 |
93 |
zyl |
2024-11-29 |
80207 |
金刚烷改性壳聚糖 AD-CS |
129 |
h |
2024-11-29 |
80208 |
DOTA-c(RGDfK) , 螯合物前体多肽 |
132 |
wyh |
2024-11-29 |
80209 |
DOTA-Lys-PEG(4)[D-Phe(6) |
88 |
kx |
2024-11-29 |
80210 |
葫芦[7]脲包裹盐酸金刚烷胺 CB[7]-AD |
116 |
h |
2024-11-29 |
80211 |
L-Threonine, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, 2,2,2-trifluoroacetate (1:) 定制 |
75 |
zcy |
2024-11-29 |
80212 |
N-金刚烷基-N-芳杂基二酰肼类化合物 |
167 |
h |
2024-11-29 |
80213 |
DOTA-奥曲肽 ,DOTA-Octreotide |
106 |
wyh |
2024-11-29 |
80214 |
CAS:147597-66-8 p-SCN-Bn-NOTA |
82 |
zyl |
2024-11-29 |
80215 |
金刚烷衍生物 |
160 |
h |
2024-11-29 |
80216 |
NOTA-EXENDIN-4 |
82 |
zyl |
2024-11-29 |
80217 |
DOTA-PDAP-PNA-肽探针 |
88 |
kx |
2024-11-29 |
80218 |
β-环糊精磁性棕榈纤维生物炭 β-CD@PFMBC |
140 |
h |
2024-11-29 |
80219 |
DOTA-octreotide ,DOTA-奥曲肽 ,大环配体多肽 |
119 |
wyh |
2024-11-29 |
80220 |
β-环糊精包埋β-胡萝卜素 β-C-β-CD |
138 |
h |
2024-11-29 |
80221 |
DOTA-8-氨基辛酸 , DOTA-8-amino octanoic acid |
87 |
kx |
2024-11-29 |
80222 |
NOTA-Me-Tetrazine NOTA-甲基四嗪 |
84 |
zyl |
2024-11-29 |
80223 |
环糊精类手性离子液体(β-CD-IL) |
219 |
h |
2024-11-29 |
80224 |
DOTA-[D-Glu(1-6) , 谷氨酸残基的结构化接头DOTA |
123 |
kx |
2024-11-29 |
80225 |
DOTA-多肽分子探针 ,RGD多肽偶联的酞菁硅光敏剂 |
102 |
wyh |
2024-11-29 |
80226 |
金属离子配合物NO2A-Butyne,2089035-56-1 |
161 |
zyl |
2024-11-29 |
80227 |
DOTA-2P-[FAPI]2, FAP抑制剂(FAPI)二聚体 |
184 |
kx |
2024-11-29 |
80228 |
1293368-74-7;DOTA标记的多肽 |
100 |
wyh |
2024-11-29 |
80229 |
透明质酸-羟丙基-β-环糊精主动靶向接枝物(HA-CDs,分子量为7,63,102 kDa) |
130 |
h |
2024-11-29 |
80230 |
载脂蛋白E衍生肽-NOTA |
123 |
zyl |
2024-11-29 |
80231 |
DOTA-HYNIC-Lys(Nal)-Urea-Glu , DOTA HYNIC-Lys(Nal)-尿素-谷氨酸 |
88 |
kx |
2024-11-29 |
80232 |
DOTA标记多肽,DOTA-cyclo(RGDyK) |
110 |
wyh |
2024-11-29 |
80233 |
NOTA-琥珀酰亚胺酯,NOTA-NHS ester,1338231-09-6 |
80 |
zyl |
2024-11-29 |
80234 |
DOTA修饰的药物分子 |
156 |
wyh |
2024-11-29 |
80235 |
聚乙烯亚胺PEI600-γ-羟丙基环糊精(γ-hy-PC) |
155 |
h |
2024-11-29 |